Skip to main content
Multiple Sclerosis Discovery Forum
Inspiring Connections
Utility Navigation
Feedback
Newsletter
RSS
Twitter
User Top Menu
Welcome, guest
Log In
Join
Why Join?
Search form
Search
About Us
Overview
Who We Are
Contact
Fan Mail
How to Cite
News & Future Directions
New Findings
News Briefs
Podcasts
News Synthesis
Essays & Opinions
Blogs
Papers
Editors' Picks
Classic Papers
Archive
Forums
Discussions
Webinars
Professional Resources
Meetings & Events
Past Meetings
Funding Opportunities
Jobs
Member Directory
Bulletin Board
Useful Links
Research Resources
Data Visualizations
Clinical Trials - Public Availability of Results
World Map
MS trials baseline
NMO History
NMO Galaxy
Map of MS Prevalence
Progressive MS Authors Galaxy
Word Cloud
MSLine
Ongoing Clinical Trials in MS
MRI-Related Clinical Trials
RRMS and CIS
Immunopathogenesis of MS
The MS Galaxy
ARR in Placebo Groups
Symptoms Prevalence
Scientific Literature TreeMap
Clinical Trials in MS
Drug-Development Pipeline
Tissue Repositories
MSGene
Animal Models
Clinical Trials
Click Here to Support MSDF
You are here
Home
Most Viewed
[Immunotherapy and infectious issues in multiple sclerosis : Self-injectable and oral drugs for immunotherapy].
Vitamin D3 Induces IDO(+) Tolerogenic DCs and Enhances Treg, Reducing the Severity of EAE.
Deletion of CTLA-4 on regulatory T cells during adulthood leads to resistance to autoimmunity.
Why this is not multiple sclerosis: a case based approach.
Diagnostic tools for assessment of urinary dysfunction in MS patients without urinary disturbances.
Alternative source of stem cells derived from human periodontal ligament: a new treatment for experimental autoimmune encephalomyelitis.
Features of anti-aquaporin 4 antibody-seronegative Thai patients with neuromyelitis optica spectrum disorders: A comparison with seropositive cases.
Increased thalamic intrinsic oscillation amplitude in relapsing-remitting multiple sclerosis associated with the slowed cognitive processing.
Evaluation of Retinoids for Induction of the Redundant Gene ABCD2 as an Alternative Treatment Option in X-Linked Adrenoleukodystrophy.
Cognitive function alone is a poor predictor of health-related quality of life in employed patients with MS: results from a cross-sectional study.
The effect of venous anatomy on the morphology of multiple sclerosis lesions: a susceptibility-weighted imaging study.
IL-1-induced Bhlhe40 identifies pathogenic T helper cells in a model of autoimmune neuroinflammation.
Vitamin D and multiple sclerosis: Potential pathophysiological role and clinical implications.
[Low back pain: atypical presentation of multiple sclerosis.]
Use of a biomarker in exposure-response analysis to support dose selection for fingolimod.
White Matter Changes in Patients with Friedreich Ataxia after Treatment with Erythropoietin.
Synergistic effects of atorvastatin and all-trans retinoic acid in ameliorating animal model of multiple sclerosis.
Isolated bilateral horizontal gaze palsy as first manifestation of multiple sclerosis.
Intrathecal immune reset in multiple sclerosis: Exploring a new concept.
Antibodies as Mediators of Brain Pathology.
Cognitive Rehabilitation for Attention and Memory in people with Multiple Sclerosis: study protocol for a randomised controlled trial (CRAMMS).
Muscle Expression of SOD1(G93A) Modulates microRNA and mRNA Transcription Pattern Associated with the Myelination Process in the Spinal Cord of Transgenic Mice.
The role of the community nurse in care provision for people with multiple sclerosis.
Urodynamic changes in mice with experimental autoimmune encephalomyelitis correlate with neurological impairment.
Effects of Brain-Derived IL-2 Deficiency and the Development of Autoimmunity on Spatial Learning and Fear Conditioning.
Pages
« first
‹ previous
…
490
491
492
493
494
495
496
497
498
…
next ›
last »